Varicella seroprevalence in healthcare workers in a tertiary hospital: an audit of cross-sectional data by unknown
Gorny et al. BMC Res Notes  (2015) 8:664 
DOI 10.1186/s13104-015-1656-0
RESEARCH ARTICLE
Varicella seroprevalence in healthcare 
workers in a tertiary hospital: an audit 
of cross-sectional data
Alexander Wilhelm Gorny*, Chikul Mittal, Sharon Saw, Indumathi Venkatachalam, Dale Andrew Fisher 
and Paul Anantharajah Tambyah
Abstract 
Background: The seroprevalence of varicella in Southeast Asia is not well described especially in healthcare workers 
(HCW) in the region. We report the varicella seroprevalence among healthcare workers from a diverse range of coun-
tries working in a tertiary care hospital in Singapore.
Methods: We audited the results of annual HCW health screening, which included a varicella assay, from the years 
2009 to 2014. During this period, there was a change in hospital policy mandating varicella immunity for all newly 
employed healthcare workers. The serological data were reviewed with employment records on occupation and 
nationality. Seroprevalence rates were determined by standard commercial enzyme linked immunosorbent assays for 
each year of testing. Odds of being immune in 2014 were compared by means of multiple logistic regression.
Results: A total of 10,585 samples were obtained from 6668 unique individuals over four separate cross-sections of 
the hospital workforce. A peak seroprevalence of 92.8 % (95 % CI 92.0–93.5) was recorded in 2014. Younger employ-
ees had a lower seroprevalence than their older colleagues. In a consolidated sample of 4875 members of the active 
workforce in October 2014, we identified that Indian nationals were less likely to be immune than their Singaporean 
national colleagues, odds ratio (OR) 0.26 (95 % CI 0.17–0.43, p < 0.001), while Chinese nationals were more likely to 
be immune, OR 4.34 (95 % CI 1.61–12.2, p = 0.004), after controlling for year of screening, gender, age-group and 
vocation. In 2014, being employed as administrative staff, OR 0.43 (95 % CI 0.29–0.64, p < 0.001) or contract service 
provider, OR 0.30 (95 % CI 0.19–0.47, p < 0.001), was also associated with a lower odds of being immune than being 
employed as a nurse.
Conclusions: There remain a small number of healthcare workers who are non-immune to varicella in our tertiary 
hospital. A new pre-employment policy of mandatory screening and vaccination may have increased rates of immu-
nity but more needs to be done to ensure that all of our employees are immune to varicella to protect our vulnerable 
patients.
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Background
Hospitals need to monitor the susceptibility of their 
employees to varicella zoster virus (VZV) in order to 
address the risks of nosocomial and occupational trans-
missions among patients, staff and visitors [1]. Although 
the infections which healthcare workers acquire from 
patients are usually self-limited and minor, the conse-
quences of nosocomial varicella infection in patients can 
be severe especially in infants and the immunocompro-
mised [2].
Varicella vaccination has been available in Singa-
pore since 1996 [3] but has not been mandated in the 
national immunization programme. This and a low 
rate of transmission are thought to have given rise to 
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national seroprevalence rates of 34.5  % in children ages 
1–6  years, 60.5  % in children 7–12  years and 71.0  % in 
ages 13–17 years as assessed between the years 2008 and 
2010 [4]. Chickenpox had been a notifiable disease in 
Singapore until 2008, after which the legal requirement 
for reporting was removed [4]. Since 2009 our hospital 
has extended voluntary free varicella vaccination to all 
employees, clinical, administrative and service partners.
The National University Hospital (NUH) in Singapore 
employed 7349 full-time staff as of 31 October 2014 in 
addition to facilities management staff who are employed 
by external service partners. Every year in October the 
hospital has provided free cardiovascular screening to its 
employees, measuring among other parameters: body 
mass index, blood pressure, fasting cholesterol and glu-
cose levels. A varicella Immunoglobulin G (IgG) assay 
was included from 2009 to establish a baseline immunity 
profile, other occupationally relevant assays, e.g. measles, 
mumps and rubella, were included in subsequent years. 
Employees who were found to be non-immune would 
later be invited for a voluntary consultation with the occu-
pational health physician, who would review electronic 
medical records and help determine the need for vacci-
nation—all at no additional cost. Mandatory serological 
assessment and vaccination previously only applied to staff 
working in high risk areas and depended on history of vac-
cination or clinical disease. A change in pre-employment 
policy effected on 01 July 2013 meant that all prospec-
tive employees were assessed for documented history of 
exposure and/or vaccination before using their serology to 
assess the need for vaccination. An audit into seropreva-
lence data generated through the annual health screening 
programme was undertaken in 2014 to better understand 
possible gaps in varicella immunisation coverage.
Methods
Our audit was conducted under the direction of the hos-
pital’s infection control committee and relied on the elec-
tronic records generated by the annual health screening 
programme from 2009 to 2014. Secondary analysis of this 
dataset was in keeping with national guidelines which 
stipulate that licensed healthcare establishments evaluate 
infection control procedures on a continuing basis [5]. 
These evaluations are governed by Singapore Ministry of 
Health regulations as stated in the Private Hospitals and 
Medical Clinics Act and are independent of our institu-
tion’s domain specific ethical review board.
All serum specimens dating back to 2009 had been 
tested using an anti-VZV enzyme-linked immunosorb-
ent IgG assay (ELISA), Euroimmun Medizinische Labor-
diagnostika AG, Germany. The manufacturers’ insert 
reports 100 % sensitivity and specificity of their assay as 
proven on 265 clinically characterised patient samples. 
In our analysis we used the manufacturer-recommended 
upper limit of the reference range for non-immunity at 
100  IU/L. This cut-off showed a 97.4  % seroprevalence 
when validated on 500 health blood-donor serum sam-
ples in Germany, reflecting the known percentage of 
infected adults. For the purposes of this audit we did not 
distinguish individuals falling into the ‘borderline’ range 
80–109 IU/L as defined by the manufacturers or explore 
their status on follow-up. Test results were coded for each 
participating employee’s unique identification number, 
gender and date of birth. The results of each screening 
exercise were compiled using Microsoft Excel software. 
Information on vocation and nationality were joined to 
these data-points using human resource records current 
as of 31 Oct 2014 using Quantum Geographic Informa-
tion System (GIS) [6].
Basic descriptive indicators for the data-set were gen-
erated using the summary and tabulation functions of 
STATA Version 13.1 (Stata Corp, College Station, TX, 
USA). We compared year-on-year seroprevalences by 
drawing binomial 95 % confidence intervals (CI) around 
point-estimates generated for each year of testing. The 
variable for age was categorised into decades of birth in 
order to account for changes in age across annual cross-
sections. Thereafter, a seroprevalence curve was plotted 
to illustrate age-specific estimates in each year of the 
health screening programme.
Using individual employee data current as of October 
2014 and the most recent serology result from all previ-
ous years of testing, we were able to review a more com-
plete cross-section of our employees in 2014, and report 
crude seroprevalence estimates by nationality and voca-
tion. The consolidated data-set was subjected to mul-
tiple logistic regression analysis comparing the odds of 
being immune across the following exposure variables: 
year result had been obtained, age, gender, nationality 
and vocation. A Strengthening the Reporting of Obser-
vational Studies in Epidemiology (STROBE) statement 
check-list [7] was used in compiling this report.
Results
Over the four batches of screening involving a total of 
6701 individuals, data on 33 (0.5 %) individuals had to be 
omitted in view of incomplete or erroneous data. Apply-
ing manufacturers’ definitions, 6134 (91.7 %) titres were 
positive, 106 (1.6 %) were borderline and 460 (6.9 %) fell 
into the negative range. In this audit we did not review 
follow-up results for ‘borderline’ individuals, and instead 
classified 89 individuals with titres 0–100  IU/L as ‘non-
immune’ and 17 individuals with titres between 101 and 
109 IU/L as ‘immune’.
VZV seroprevalence was not assessed in 2010 or 2013 
in view of competing priorities during the annual staff 
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health screening exercise. The majority of employees 
presented for screening more than once in all 4 years of 
screening (see Table 1), but the highest participation rate 
was registered in 2014 covering 44  % of full-time staff, 
owing to enhanced health promotion efforts to partici-
pate in health screening. The average age in all four sets 
of data ranged between 38 and 40 years. The age-group 
specific proportions of female staff ranged from 79 to 
91 %.
Crude point-estimates of varicella seroprevalence 
declined from 2009 through to 2012, followed by an 
increase to 93.9  % (95  % CI 93.1–94.7) in 2014—see 
Fig.  1. This development coincided with the change in 
pre-employment policy. The seroprevalence curves for 
each year were similar in shape across the different age 
groups—see Fig. 2.
For the most recent and most complete year of 2014, 
omitting erroneous data, we were able to identify the 
immunity status of 4464 members of staff by consoli-
dating data from 2009 to 2014, thus representing 60.7 % 
(4464/7349) of the directly employed workforce. We 
compared the demographic characteristics of participat-
ing staff members against the whole hospital in Table 2. 
We counted 411 contracted service-provider staff in the 
2014 sample. Adding service-providers into the 2014 
sample of 4875 individuals, we calculated an overall sero-
prevalence of 92.8 % (95 % CI 92.1–93.5) which was not 
significantly lower than the 2014 point estimate.
We analysed the seropositivity for the different voca-
tions and nationalities, generating crude seropreva-
lence estimates with 95 % CIs. The results are shown in 
Tables 3 and 4.
We conducted a multiple logistic regression analysis 
on the immunity status (Table  5). The year of sampling 
was included in the final model in order to adjust for the 
confounding effect of a change in policy. There was no 
significant difference in odds of being immune between 
male and female employees. The adjusted odds of being 
immune were significantly lower for employees born in 
more recent decades. Employees of Indian nationality 
were significantly less likely to be immune than their Sin-
gaporean co-workers while Chinese nationals had higher 
odds of immunity. Those working in administrative areas 
or as service-providers were significantly less likely to be 
seropositive than employees in the nursing vocation.
Discussion
We have reported the estimated seroprevalence rates of 
a tertiary hospital in Singapore from 2009 to 2014, and 
we have found significantly higher immunity 1 year after 
instituting a mandatory varicella seroprotection policy. 
However, we still have a small proportion of individuals 
who are not immune to varicella at least by serological 
screening. Considering how our methods did not include 
follow-up testing for ‘borderline’ titres, it is likely that we 
Table 1 Characteristics of cross-sectional samples 2009–2014, n = 10,525 data-points





≤1959 1960–1969 1970–1979 ≥1980
2009 Female (2023) 361 428 786 448 39 (11) 1030 (43) 2388
Male (365) 98 70 132 65
2011 Female (1885) 238 357 680 610 38 (10) 552 (25) 2199
Male (314) 65 63 109 77
2012 Female (2017) 219 343 666 789 38 (10) 688 (30) 2301
Male (284) 54 48 101 81
2014 Female (3071) 380 556 944 1191 40 (11) 1806 (50) 3637
Male (566) 96 106 186 179
Fig. 1 Crude seroprevalence by year of screening with 95 % con-
fidence intervals. We calculated and plotted crude seroprevalence 
figures for each year of health screening. Error bars were computed 
using binomial 95 % confidence intervals for the proportions of 
employees found to be immune on varicella serology
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have overestimated the sensitivity and specificity of our 
serological test. We could therefore infer that the true 
proportion of non-immune individuals may in fact be 
larger than estimated. Multiple logistic regression analy-
sis showed lower immunity among employees from India 
and those working in non-clinical vocations.
Our crude annual seroprevalence estimates were in 
keeping with reported national rates for adults which 
ranged between 84.0  % (ages 18–29) and 96.4  % (ages 
70–79) [3]. The logistic regression performed on the 2014 
data showed that staff born in the 1970s and 1980s were 
at significantly lower odds of being immune than those 
born in the 1950s, even after controlling for sex, national-
ity and vocation.
One paediatric hospital in Singapore had previously 
estimated that between 92.3 and 93.5  % of its health-
care workers (HCW) were immune to VZV, using 
self-reported history of infection and objective serum 
samples where employees were unsure of their history 
[8]. One hospital in Taiwan reported a laboratory-con-
firmed seroprevalance rate of 91.1  % among its HCWs 
[9]. Our consolidated hospital-wide seroprevalence of 
92.8 % (95 % CI 92.1–93.5) in 2014 was comparable. Still, 
we were not able to achieve the rates reported in Japanese 
healthcare institutions which can range between 94.7 and 
97.4  % [10–12]. Data on HCWs in the wider Southeast 
Asian region are not available for comparison, save for a 
small sample studied in Malaysia, which showed a sero-
prevalence of 84.4 % [13].
In this audit we also described a multi-national work-
force which comprised 51  % Singaporean citizens and 
49  % foreign nationals, drawn predominantly from 
Southeast, East and South Asia. We were able to draw 
only limited comparisons with multi-national HCW data 
from Saudi Arabia [14] who reported an 81 % seropreva-
lence among HCWs from the “Far East”.
Our multiple logistic regression showed that the odds 
of being immune was higher for People’s Republic of 
China (PRC) nationals than for Singaporeans. While we 
were unable to find data on HCWs from the PRC, we 
noted that pregnant women in Hong Kong [15], who 
are likely of similar ages compared to our HCWs, were 
shown to have a seroprevalence as high as 95.4 %.
Fig. 2 Age-group specific seroprevalence with 95 % confidence 
intervals. We have plotted age-group specific seroprevalence rates 
with error bars for the health screenings performed in (1) 2009, (2) 
2011, (3) 2012 and (4) 2014. For the purpose of illustration we have 
added the seroprevalence curve for 2014
Table 2 Characteristics of hospital employees in october 2014
Participated in at least one screening since 2009 (% 
of total)
No health screening data (% of total) Hospital total
Overall 4465 (60.4) 2929 (39.6) 7394
Gender
 Female 3928 (64.7) 2145 (35.3) 6073
 Male 537 (40.7) 784 (59.4) 1321
Vocation
 Nursing 2221 (65.4) 1176 (34.6) 3397
 Allied health 818 (61.5) 513 (38.5) 1331
 Ancillary 744 (61.4) 467 (38.6) 1211
 Doctor/dentist 124 (18.6) 543 (81.4) 667
 Administrators 558 (70.8) 230 (29.2) 788
Age-group by year of birth
 ≤1959 558 (68.7) 254 (31.3) 812
 1960–1969 783 (65.6) 411 (34.4) 1194
 1970–1979 1429 (60.5) 934 (39.5) 2363
 ≥1980 1695 (56.1) 1329 (44.0) 3024
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The differences in immunity seen between nationali-
ties might be explained by past observations how a tropi-
cal climate affects the transmission patterns of varicella, 
allowing the disease to behave more like a disease of early 
adulthood [16, 17]. This would explain higher immunity 
in employees from the PRC, a predominantly temper-
ate country, compared to the rates seen in Singapore, 
Malaysia, India, the Philippines and Myanmar, countries 
located within the tropics. The reasons for this geograph-
ical distribution of sero-epidemiology have never been 
completely explained.
We were especially interested to see that Indian nation-
ality in our HCW population was associated with a 
lower odds of being seropositive. We found literature 
reporting seroprevalence rates between 88 and 91  % in 
the young adult population in India [18]. Data on Sin-
gaporean military recruits reflected that ethnic Indians 
had a lower seroprevalence rate than ethnic Chinese or 
Malays [19]. This finding, however, was not reproduced 
in national health survey data [3]. We would infer that 
varicella immunity was less likely a function of ethnicity, 
more likely a result of birthplace or nationality. Again, the 
reasons for a lower seroprevalence among those born in 
India working in Singapore has not been fully explained.
Past policy had made provisions for HCWs to be 
offered free vaccination in conjunction with outbreak 
investigations and annual screening exercises. The sig-
nificant increase in seroprevalence recorded in 2014 
coincided with a change in pre-employment policy 1 year 
prior, which required new employees to be serologically 
screened and vaccinated. Those found to be non-immune 
received two doses of vaccine. Sero-conversion data were 
not collected.
The fact that administrative staff and service provid-
ers were less likely to be immune than their nursing col-
leagues is in keeping with past vaccination policies which 
favoured clinicians and the higher likelihood of clinical 
staff being exposed through their line of work. Nonethe-
less, given that varicella is an airborne infectious disease 
[20] which does not discriminate between vocations, 
more could be done to ensure that non-clinical members 
Table 3 Crude seroprevalence by  vocation in  2014 
(n = 4875)
Vocation n Seroprevalence in % 
(binomial 95 % CI)
Nursing 2221 93.8 (92.7–94.8)
Allied health 817 93.5 (91.6–95.1)
Ancillary 744 93.0 (90.9–94.7)
Doctor/dentist 124 94.4 (88.7–97.7)
Administrators 558 90.6 (88.0–93.0)
Service-provider 411 88.1 (84.5–91.0)
Table 4 Crude seroprevalence by  nationality in  2014 
(n = 4875)
Nationality n Seroprevalence in %  
(binomial 95 % CI)
Singapore 2660 93.2 (92.1–94.1)
Philippines 776 92.9 (90.8–94.6)
Malaysia 418 94.7 (92.1–96.7)
China 257 98.4 (96.0–99.6)
India 160 82.5 (75.7–88.0)
Myanmar 107 96.3 (90.7–99.0)
Other 86 91.9 (83.9–96.7)
Missing 411 88.1 (84.5–91.0)
Table 5 Multiple logistic regression on  final immune sta-
tus in 2014 (n = 4875)
a Missing data on nationality was perfectly collinear with service-provider 
vocation
Exposure variable Odds ratio p value 95 % CI
Lower Upper
Year
 2009 1.00 – – –
 2011 1.95 0.051 0.998 3.82
 2012 0.927 0.775 0.552 1.56
 2014 2.51 <0.001 1.53 4.11
Gender
 Female 1.00 – – –
 Male 0.797 0.158 0.582 1.09
Age-group by year of birth
 ≤1959 1.00 – – –
 1960–1969 0.563 0.052 0.316 1.00
 1970–1979 0.313 <0.001 0.187 0.525
 ≥1980 0.209 <0.001 0.126 0.348
Vocation
 Nursing 1.00 – – –
 Allied health 0.896 0.545 0.628 1.28
 Ancillary 0.591 0.006 0.404 0.862
 Doctor/dentist 1.02 0.959 0.441 2.37
 Admin 0.435 <0.001 0.294 0.642
 Service-provider 0.302 <0.001 0.193 0.473
Nationality
 Singapore 1.00 – – –
 Philippines 0.806 0.239 0.563 1.15
 Malaysia 1.29 0.287 0.808 2.05
 China 4.43 0.004 1.61 12.2
 India 0.268 <0.001 0.166 0.433
 Myanmar 1.63 0.351 0.584 4.55
 Others 0.820 0.634 0.362 1.86
 Missinga 1.00 – – –
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of the workforce are vaccinated. Given a fairly consistent 
rate of staff turn-over, it remains to be seen whether the 
seroprevalence will continue to rise or plateau at the 2014 
level.
Our findings and analysis were limited by the over-
all rates of participation in health screening; our con-
solidated data-set for 2014 failed to capture results for 
two-fifths of the hospital’s full-time staff. Doctors, male 
members of staff and younger individuals were over-rep-
resented in this group. Given that the purpose of annual 
health screening was chronic disease prevention, we had 
to acknowledge a selection bias for older participants. 
Given that younger staff members were less likely to have 
been immune, we had to concede that our seroprevalence 
figures may have represented an overestimate.
A post hoc review of missing data showed that human 
resource records lacked information on the nationalities 
of employees working for service-provider companies. 
We did not include vaccination status in our analysis as 
this information was not captured as part of the screen-
ing exercise. Observed hospital-wide trends might have 
been driven by changes in seroprevalence within non-
clinical staff, whose vaccination may play a relatively 
smaller role in total patient safety. Nevertheless, some of 
our findings may help to inform vaccination policy across 
hospitals in Singapore and the wider Southeast Asian 
region.
Conclusions
Having reviewed 5  years of data, it has become evident 
that certain sub-populations in our workforce might 
benefit from additional screening and vaccination meas-
ures. Future studies would need to include immunisa-
tion records to shed light on whether immunity has 
been acquired naturally or through vaccination. Despite 
a mandatory policy for new staff, we still have a residual 
population who are not immune to varicella. These indi-
viduals could pose a potential risk to themselves and to 
our patients who may be vulnerable to the complications 
of varicella. We have recorded improvements in sero-
positivity but more needs to be done to ensure that staff, 
patients and visitors in our hospitals are protected from 
this vaccine preventable infectious disease.
Abbreviations
CI: confidence interval; ELISA: enzyme-linked immunosorbent assay; HCW: 
healthcare worker; OR: odds ratio; PRC: People’s Republic of China; STROBE: 
Strengthening the Reporting of Observational Studies in Epidemiology; VZV: 
varicella zoster virus.
Authors’ contributions
AWG carried out the audit of screening data, performed the statistical analyses 
and drafted the manuscript. CM participated as a co-auditor and contributed 
to the statistical analyses. SS and IV supervised AG and CM in their work, pro-
viding specialist expertise in the fields of clinical biochemistry and infectious 
disease respectively. PAT conceived of the audit, participated in its coordina-
tion and helped to draft the manuscript. DAF authorised the audit in his 
capacity as Chairman of the hospital’s infection control committee. All authors 
read and approved the final manuscript.
Acknowledgements
The authors would like to acknowledge Ms Suhanah Alwi and Ms Clara Wee, 
from the Department of Human Resources, who granted permission to access 
human resource data. Lastly, the authors would also like to extend their 
gratitude to the head and staff of the National University Occupational Health 
Clinic, Dr Judy Sng, Mr Grant Ciccone and Ms Jareena Salim, for the hard work 
invested in conducting annual health screenings.
Competing interests
The authors declare that they have no competing interests.
Received: 14 April 2015   Accepted: 2 November 2015
References
 1. Advisory Committee on Immunization Practices, and Centers for Disease 
Control and Prevention. Immunization of health-care personnel: recom-
mendations of the Advisory Committee on Immunization Practices 
(ACIP). MMWR. Recomm Rep Morb Mortal Week Rep. Recommendations 
and Reports/Centers for Disease Control. 2011;60(RR-7):1.
 2. Sydnor E, Perl TM. Healthcare providers as sources of vaccine-preventable 
diseases. Vaccine. 2014;32(38):4814–22.
 3. Fatha N, Ang LW, Goh KT. Changing seroprevalence of varicella zoster 
virus infection in a tropical city state, Singapore. Int J Inf Dis. 2014;22:73–7.
 4. Ang LW, Kita Y, James L, Cutter JL. A 20-year epidemiological review of 
the seroprevalence of varicella zoster virus infection among children and 
adolescents in Singapore. Epidemiol News Bulletin Q. 2013;39(1):1–8.
 5. Director of Medical Services, Ministry of Health, Singapore. Guidelines for 
private hospital, medical clinics and laboratories under the private hos-




Accessed 04 Oct 2015.
 6. Thiede R, Sutton T, Duester H, Sutton M. Quantum GIS training manual 
release 1.0. 2014. http://manual.linfiniti.com/LinfinitiQGISTrainingManual-
en.pdf. Accessed 08 Mar 2015.
 7. von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke 
JP. Strobe initiative. the strengthening the reporting of observational 
studies in epidemiology (STROBE) statement: guidelines for reporting 
observational studies. Prev Med. 2007;45(4):247–51.
 8. Chong CY, Lim SH, Ng WYM, Tee N, Lin RVTP. Varicella screening and 
vaccination for healthcare workers at KK Women’s and Children’s Hospital. 
Ann Acad Med Singap. 2004;33(2):243–7.
 9. Wu MF, Yang YW, Lin WY, Chang CY, Soon MS, Liu CE. Varicella zoster 
virus infection among healthcare workers in Taiwan: seroprevalence 
and predictive value of history of varicella infection. J Hosp Infect. 
2012;80(2):162–7.
 10. Kumakura S, Shibata H, Onoda K, Nishimura N, Matsuda C, Hirose M. Sero-
prevalence survey on measles, mumps, rubella and varicella antibodies 
in healthcare workers in Japan: sex, age, occupational-related differences 
and vaccine efficacy. Epidemiol Infect. 2014;142(01):12–9.
 11. Hatakeyama S, Moriya K, Itoyama S, Nukui Y, Uchida M, Shintani Y, 
et al. Prevalence of measles, rubella, mumps, and varicella antibodies 
among healthcare workers in Japan. Infect Control Hosp Epidemiol. 
2004;25(7):591–4.
 12. Kanamori H, Tokuda K, Ikeda S, Endo S, Ishizawa C, Hirai Y, et al. Prevac-
cination antibody screening and immunization program for healthcare 
personnel against measles, mumps, rubella, and varicella in a Japanese 
Tertiary Care Hospital. Tohoku J Exp Med. 2014;234(2):111–6.
 13. Sam IC, Tariman H, Chan YF, Bador MK, Yusof MM, Hassan H. Varicella-zos-
ter virus seroprevalence in healthcare workers in Kuala Lumpur, Malaysia. 
Med J Malays. 2008;63(5):429–30.
Page 7 of 7Gorny et al. BMC Res Notes  (2015) 8:664 
 14. Almuneef M, Dillon J, Abbas MF, Memish Z. Varicella zoster virus immu-
nity in multinational health care workers of a Saudi Arabian hospital. Am J 
Inf Control. 2006;31(6):375–81.
 15. Fung LWY, Lao TT, Suen SSH, Chan OK, Lau TK, Ngai KL, et al. Seropreva-
lence of varicella zoster virus among pregnant women in Hong Kong: 
comparison with self-reported history. Vaccine. 2011;29(46):8186–8.
 16. Lee BW. Review of varicella zoster seroepidemiology in India and South-
east Asia. Trop Med Int Health. 1998;3(11):886–90.
 17. Lolekha S, Tanthiphabha W, Sornchai P, Kosuwan P, Sutra S, Warachit 
B, et al. Effect of climatic factors and population density on varicella 
zoster virus epidemiology within a tropical country. Am J Trop Med Hyg. 
2001;64(3):131–6.
 18. Lokeshwar MR, Agrawal A, Subbarao SD, Chakraborty MS, Prasad AR, 
Weil J, et al. Age related seroprevalence of antibodies to varicella in India. 
Indian Pediatr. 2000;37(7):714–9.
 19. Dashraath P, Ong E, Lee VJ. Seroepidemiology of varicella and the reli-
ability of a self-reported history of varicella infection in Singapore military 
recruits. Ann Acad Med Singap. 2007;36(8):636–41.
 20. Menkhaus N, Lanphear B, Linnemann C. Airborne transmission of 
varicella-zoster virus in hospitals. Lancet. 1990;336(8726):1315.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
